On Apr 28, 2026, CDNA reported earnings of 0.34 USD per share (EPS) for Q1 26, beating the estimate of 0.13 USD, resulting in a 149.63% surprise. Revenue reached 117.70 million, compared to an expected 106.25 million, with a 10.78% difference. The market reacted with a +27.60% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 11 analysts forecast an EPS of 0.23 USD, with revenue projected to reach 116.33 million USD, implying an decrease of -32.35% EPS, and decrease of -1.17% in Revenue from the last quarter.